JP2013521497A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013521497A5 JP2013521497A5 JP2012556133A JP2012556133A JP2013521497A5 JP 2013521497 A5 JP2013521497 A5 JP 2013521497A5 JP 2012556133 A JP2012556133 A JP 2012556133A JP 2012556133 A JP2012556133 A JP 2012556133A JP 2013521497 A5 JP2013521497 A5 JP 2013521497A5
- Authority
- JP
- Japan
- Prior art keywords
- xid
- hcv
- subject
- specimen
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 25
- 210000003719 b-lymphocyte Anatomy 0.000 claims 20
- 241000711549 Hepacivirus C Species 0.000 claims 18
- 206010028980 Neoplasm Diseases 0.000 claims 10
- 201000011510 cancer Diseases 0.000 claims 10
- 230000036210 malignancy Effects 0.000 claims 10
- 206010047115 Vasculitis Diseases 0.000 claims 9
- 201000003278 cryoglobulinemia Diseases 0.000 claims 9
- 150000007523 nucleic acids Chemical group 0.000 claims 9
- 108060003951 Immunoglobulin Proteins 0.000 claims 7
- 102000018358 immunoglobulin Human genes 0.000 claims 7
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 6
- 208000015181 infectious disease Diseases 0.000 claims 4
- 208000024891 symptom Diseases 0.000 claims 4
- 210000004602 germ cell Anatomy 0.000 claims 3
- 108090000623 proteins and genes Proteins 0.000 claims 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 2
- 108010047041 Complementarity Determining Regions Proteins 0.000 claims 2
- 108010004729 Phycoerythrin Proteins 0.000 claims 2
- 210000004369 blood Anatomy 0.000 claims 2
- 239000008280 blood Substances 0.000 claims 2
- 210000001124 body fluid Anatomy 0.000 claims 2
- 239000010839 body fluid Substances 0.000 claims 2
- 238000013399 early diagnosis Methods 0.000 claims 2
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 claims 2
- 108020004707 nucleic acids Proteins 0.000 claims 2
- 102000039446 nucleic acids Human genes 0.000 claims 2
- 208000003950 B-cell lymphoma Diseases 0.000 claims 1
- 108091035707 Consensus sequence Proteins 0.000 claims 1
- 101100341519 Homo sapiens ITGAX gene Proteins 0.000 claims 1
- 102100022297 Integrin alpha-X Human genes 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 238000000684 flow cytometry Methods 0.000 claims 1
- 208000010710 hepatitis C virus infection Diseases 0.000 claims 1
- 238000004393 prognosis Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30916110P | 2010-03-01 | 2010-03-01 | |
| US61/309,161 | 2010-03-01 | ||
| PCT/US2011/026455 WO2011109285A2 (en) | 2010-03-01 | 2011-02-28 | Prognostic marker for cryoglobulinemic vasculitis and b cell malignancies in hcv infected patients |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013521497A JP2013521497A (ja) | 2013-06-10 |
| JP2013521497A5 true JP2013521497A5 (enExample) | 2014-04-24 |
| JP6095984B2 JP6095984B2 (ja) | 2017-03-15 |
Family
ID=44542788
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012556133A Expired - Fee Related JP6095984B2 (ja) | 2010-03-01 | 2011-02-28 | Ｈｃｖ感染患者のクリオグロブリン血症性血管炎およびｂ細胞悪性腫瘍のための予後マーカー |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US9719141B2 (enExample) |
| EP (1) | EP2542892A4 (enExample) |
| JP (1) | JP6095984B2 (enExample) |
| AU (1) | AU2011223906B2 (enExample) |
| BR (1) | BR112012021795A2 (enExample) |
| CA (1) | CA2791676A1 (enExample) |
| WO (1) | WO2011109285A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103184216B (zh) * | 2011-12-27 | 2015-03-18 | 深圳华大基因科技有限公司 | 用于扩增免疫球蛋白重链cdr3编码序列的引物组合物及其用途 |
| US11781112B2 (en) | 2016-03-06 | 2023-10-10 | Kareem Thomas Robinson | Method of generating antigen-specific immunological memory in a subject that rejects classical vaccines |
| RU2642626C1 (ru) * | 2016-11-03 | 2018-01-25 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) | Способ прогнозирования развития криоглобулинемического васкулита у больных хроническим гепатитом с |
| EP3665705B1 (en) | 2017-08-08 | 2024-12-18 | Fresenius Medical Care Holdings, Inc. | Systems and methods for treating and estimating progression of chronic kidney disease |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITRM20020049A1 (it) | 2002-01-30 | 2003-07-30 | Biostrands S R L | Frammenti fab di anticorpi monoclonali umani diretti contro la glicoproteina e2 di hcv e dotati di potere neutralizzante in vitro. |
| US8178303B2 (en) | 2003-12-04 | 2012-05-15 | Wake Forest University Health Sciences | Increasing the speed of cryoglobulin precipitation |
| EP1801116A1 (en) | 2005-12-21 | 2007-06-27 | F. Hoffmann-La Roche Ag | HCV replicon shuttle vectors |
-
2011
- 2011-02-28 CA CA2791676A patent/CA2791676A1/en not_active Abandoned
- 2011-02-28 WO PCT/US2011/026455 patent/WO2011109285A2/en not_active Ceased
- 2011-02-28 JP JP2012556133A patent/JP6095984B2/ja not_active Expired - Fee Related
- 2011-02-28 BR BR112012021795A patent/BR112012021795A2/pt not_active IP Right Cessation
- 2011-02-28 US US13/581,759 patent/US9719141B2/en not_active Expired - Fee Related
- 2011-02-28 AU AU2011223906A patent/AU2011223906B2/en not_active Ceased
- 2011-02-28 EP EP11751140.2A patent/EP2542892A4/en not_active Withdrawn
-
2015
- 2015-09-23 US US14/863,220 patent/US20160083801A1/en not_active Abandoned
-
2017
- 2017-09-11 US US15/701,379 patent/US20180002763A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109765378B (zh) | 一种新的肝硬化或肝纤维化标志物 | |
| JP2008249727A5 (enExample) | ||
| WO2010017515A2 (en) | Breast cancer specific markers and methods of use | |
| CN107541563B (zh) | 一种用于早期诊断、预测脓毒血症并发急性肾损伤的分子标记物、试剂盒及应用 | |
| JP6092655B2 (ja) | テスト体液サンプルの分類方法 | |
| WO2009130176A9 (en) | Antiviral therapy | |
| CN107267649B (zh) | Stradb在哮喘早期诊断中的应用 | |
| RU2013113314A (ru) | Способы выявления антител против не4 и способы диагностики и/или прогнозирования состояний, ассоциированных с экспрессирующими не4 клетками | |
| CN107164536B (zh) | Mrnip基因在重度抑郁症诊断中的应用 | |
| JP2013521497A5 (enExample) | ||
| CN107164529A (zh) | 一种与哮喘发生发展相关的基因的应用 | |
| Knight et al. | Detection of WA B cells in hepatitis C virus infection: a potential prognostic marker for cryoglobulinemic vasculitis and B cell malignancies | |
| CN108796074B (zh) | 检测环状RNA circRNF13的试剂在制备肿瘤辅助诊断制剂上的应用及试剂盒 | |
| CN108660215B (zh) | 检测circMAN1A2和circRNF13试剂的应用及试剂盒 | |
| Young et al. | A triad of somatic mutagenesis converges in self-reactive B cells to cause a virus-induced autoimmune disease | |
| JP6095984B2 (ja) | Ｈｃｖ感染患者のクリオグロブリン血症性血管炎およびｂ細胞悪性腫瘍のための予後マーカー | |
| CN110331201A (zh) | 宫颈鳞癌相关生物标志物及其应用 | |
| CN108913769A (zh) | 早期诊断心肌梗死的分子标志物 | |
| CN108410978A (zh) | 重度抑郁症相关基因及其在诊断中的应用 | |
| CN104884636A (zh) | Hbv对肝细胞癌癌症患者临床结果的影响 | |
| EP3055426B1 (en) | Detection of hepatitis delta virus (hdv) for the diagnosis and treatment of sjögren's syndrome and lymphoma | |
| CN106957905A (zh) | 一种用于评估肿瘤免疫治疗效果的分子检测方法及引物组合物及试剂盒 | |
| CN108676880B (zh) | 一种人血清afp阴性肝细胞癌检测试剂盒 | |
| CN106947818B (zh) | 一种诊治结肠腺癌的分子标志物 | |
| KR101351234B1 (ko) | 간암 진단용 마커로서 Ｇａｎｋｙｒｉｎ의 용도 |